Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-retroviral, antibiotic, anticonvulsant, antidepressant, antifibrinolytics, antigout agent, antihelmintic, antihistamine, antihyperlipoproteinemic, antimycotic, antifungal, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antiulcer, antiulcerative, anxiolytic, aprepitant, bile acid analogue, calcimimetic agent, cardiovascular agent, chronic alcoholism, treatment of hyperphosphatemia, hemorrheologic agent, hypercholesterolemia, hypophosphatemic agent, immune-suppressant, loop diuretic, NSAIDs, anti-hyperkalaemia, nucleoside inhibitor, OAB treatment, phenylalanine reducer, phosphate binder, reversal of neuro-muscular blocking agent, skeletal muscle relaxant, and topical anti-infectives. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical development, impurity synthesis, and regulatory support. In addition, the company exports its products. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.
Low
422.00
High
774.00
Low
698.00
High
736.95
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
How Solara Active Pharma Sciences Limited stacks up against its Drug Manufacturers - Specialty & Generic peers on price, valuation and the 52-week range. Tap any column header to sort.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 1M % | 1Y % | 52W H/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SOLARA Solara Active Pharma Sciences Limited | 715.00 | 1.43% | 0.00 | -0.67 | 3,436 | 13.50% | 15.89% | 774.00 / 422.00 |
| 2 | AARTIDRUGS Aarti Drugs Limited | 419.00 | 2.76% | 20.01 | 20.94 | 3,824 | 0.95% | 10.78% | 534.00 / 318.95 |
| 3 | AARTIPHARM Aarti Pharmalabs Limited | 980.00 | 2.75% | 44.50 | 22.02 | 8,854 | 16.11% | 15.70% | 1,002.40 / 585.00 |
| 4 | ABBOTINDIA Abbott India Limited | 26,850.00 | 1.01% | 35.33 | 759.88 | 57,033 | 1.13% | 15.17% | 30,655.00 / 25,135.00 |
| 5 | AHCL ANLON HEALTHCARE LIMITED | 32.86 | 4.97% | 13.55 | 2.42 | 1,746 | 112.69% | 261.10% | 37.24 / 10.37 |
| 6 | AJANTPHARM Ajanta Pharma Limited | 3,586.00 | 0.96% | 39.48 | 90.83 | 44,748 | 0.17% | 43.15% | 3,796.00 / 2,379.30 |
| 7 | AKUMS AKUMS DRUGS AND PHARMA L | 815.80 | 0.33% | 42.83 | 19.05 | 12,490 | 5.06% | 78.90% | 838.80 / 409.30 |
| 8 | ALIVUS Alivus Life Sciences Limited | 1,380.00 | 0.05% | 28.15 | 49.03 | 16,942 | 0.80% | 47.27% | 1,493.80 / 819.00 |
| 9 | ALKEM Alkem Laboratories Limited | 5,215.00 | 1.00% | 28.90 | 180.45 | 62,353 | 3.03% | 1.79% | 5,933.50 / 5,051.00 |
| 10 | AMRUTANJAN Amrutanjan Health Care Limited | 516.00 | 0.24% | 27.63 | 18.67 | 1,483 | 1.70% | 25.36% | 760.15 / 476.50 |
| 11 | APLLTD Alembic Pharmaceuticals Limited | 819.00 | 0.78% | 23.22 | 35.27 | 16,099 | 0.26% | 12.03% | 998.00 / 635.80 |
| 12 | ASTRAZEN AstraZeneca Pharma India Limited | 6,010.00 | 2.85% | 88.58 | 67.85 | 15,078 | 17.26% | 28.96% | 9,849.50 / 5,986.00 |
| 13 | AUROPHARMA Aurobindo Pharma Limited | 1,666.30 | 0.34% | 26.03 | 64.00 | 96,479 | 3.88% | 62.92% | 1,740.00 / 1,066.80 |